Metaphore

Cambridge, United States Founded: 2021 • Age: 5 yrs
Provider of machine language and computational platform for drug discovery
Request Access

About Metaphore

Metaphore is a company based in Cambridge (United States) founded in 2021 by Lovisa Afzelius and Daniel Acker.. Metaphore has raised $50 million across 1 funding round from investors including Flagship Pioneering. Metaphore offers products and services including MIMIC Platform. Metaphore operates in a competitive market with competitors including Asimov, Cellarity, Panakeia, Evolved By Nature and Algorithmic Biologics, among others.

  • Headquarter Cambridge, United States
  • Founders Lovisa Afzelius, Daniel Acker
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $50 M (USD)

    in 1 rounds

  • Latest Funding Round
    $50 M (USD), Series C

    May 16, 2023

  • Investors
  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Metaphore

Metaphore offers a comprehensive portfolio of products and services, including MIMIC Platform. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Uses machine learning and molecular mimicry for therapeutic insights and drug development.

People of Metaphore
Headcount 10-50
Employee Profiles 17
Employee Profiles
People
Ben Goldberg
Scientist Ii, Discovery Sciences And Technology
People
Chaz Hinzman
Head Of Strategy And Operations
People
Marcin Paduch
Vice President, Head Of Platform Biology
People
Susana Gordo
Senior Director Of Translational Science

Unlock access to complete

Funding Insights of Metaphore

Metaphore has successfully raised a total of $50M through 1 strategic funding round. The most recent funding activity was a Series C round of $50 million completed in May 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 1
  • Last Round Series C — $50.0M
  • First Round

    (16 May 2023)

  • Investors Count 1
Date Amount Transaction Name Valuation Lead Investors Investors
May, 2023 Amount Series C - Metaphore Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Metaphore

Metaphore has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Flagship Pioneering. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Investor Description Founded Year Domain Location
Life sciences-focused venture capital firm
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Metaphore

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Metaphore

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Metaphore Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Metaphore

Metaphore operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Asimov, Cellarity, Panakeia, Evolved By Nature and Algorithmic Biologics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Provider of integrated suite for advanced genetic design and manufacturing
domain founded_year HQ Location
Developer of drugs to treat various diseases
domain founded_year HQ Location
AI-based software is provided for cancer diagnosis and precision treatment.
domain founded_year HQ Location
Digital technology for biomedicinal molecule development in research is utilized.
domain founded_year HQ Location
Provider of software solutions for molecular diagnostics and discovery
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Metaphore

Frequently Asked Questions about Metaphore

When was Metaphore founded?

Metaphore was founded in 2021 and raised its 1st funding round 2 years after it was founded.

Where is Metaphore located?

Metaphore is headquartered in Cambridge, United States. It is registered at Cambridge, Massachusetts, United States.

Who is the current CEO of Metaphore?

Lovisa Afzelius is the current CEO of Metaphore. They have also founded this company.

Is Metaphore a funded company?

Metaphore is a funded company, having raised a total of $50M across 1 funding round to date. The company's 1st funding round was a Series C of $50M, raised on May 16, 2023.

What does Metaphore do?

Provider of machine language and computational platform for drug discovery. The company uses biomimicry and machine learning to unleash the transformational medicinal potential of functional molecular mimics. The MIMiC platform, developed by the company is a computationally driven bioplatform for developing novel therapies in which function, specificity, and selectivity may be optimized.

Who are the top competitors of Metaphore?

Metaphore's top competitors include Asimov, Cellarity and Panakeia.

What products or services does Metaphore offer?

Metaphore offers MIMIC Platform.

Who are Metaphore's investors?

Metaphore has 1 investor. Key investors include Flagship Pioneering.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available